Celularity, the venture-backed developer of novel cell therapies for cancer treatments, has received an initial clearance from the Food and Drug Administration to begin early-stage clinical trials on
Ready for an ethics debate? DNA researcher Craig Venter (pictured right) "has built a synthetic chromosome out of laboratory chemicals and is poised to announce the creation of the first new arti